LEP and cancer: For instance, the co-treatment of MDA-MB231 cells with leptin and cAMP elevating agents (8-pCPT-2′-O-Me-cAMP, 8-Br-cAMP) blocked the proliferative effect of leptin and induced apoptosis in cancer cells by downregulating Bcl2 [58].